跳至主要内容
临床试验/ISRCTN07210906
ISRCTN07210906已完成未知

Efficacy and safety of hepcidin-based screen-and-treat approaches using two different doses vs a standard universal approach of iron supplementation in young children in rural Gambia: a double-blind randomized controlled trial

Medical Research Council (MRC) (UK)0 个研究点目标入组 393 人开始时间: 2014年7月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
393

研究概览

简要总结

2016 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/27585745 protocol 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27852523 results 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36521942/ (added 16/12/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Apparently healthy
  • 2. Age: 6 to 23 months
  • 3. Not severely malnourished (HAZ, WAZ >-3 SD and WHZ > -2 SD)
  • 4. Hb = 7 g/dL and < 11 g/dL
  • 5. Free of malaria
  • 6. Resident in the study area
  • 7. Ability and willingness to comply with the study protocol (weekly study visits with finger prick blood sampling)
  • 8. Informed consent given by parent or guardian

排除标准

  • 1. Congenital disorders
  • 2. Chronic disease
  • 3. Regular medication
  • 4. Currently participating in another study

研究者

发起方
Medical Research Council (MRC) (UK)

相似试验